Company Analysis Ascletis Pharma Inc
1. Summary
Advantages
- Price (1.71 $) is less than fair price (2.66 $)
- The stock's return over the last year (175.05%) is higher than the sector average (-6.35%).
Disadvantages
- Dividends (0%) are below the sector average (4.26%).
- Current debt level 0.3619% has increased over 5 years from 0.3375%.
- The company's current efficiency (ROE=-100.44%) is lower than the sector average (ROE=9.99%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Ascletis Pharma Inc | Index | ||
|---|---|---|---|
| 7 days | 0% | -0.7% | 1.1% |
| 90 days | 42.5% | 0.2% | 3% |
| 1 year | 175.1% | -6.3% | 17% |
ASCLF vs Sector: Ascletis Pharma Inc has outperformed the "" sector by 181.4% over the past year.
ASCLF vs Market: Ascletis Pharma Inc has outperformed the market by 158.09% over the past year.
Stable price: ASCLF is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ASCLF with weekly volatility of 3.37% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (1.71 $) is lower than the fair price (2.66 $).
Price significantly below the fair price: The current price (1.71 $) is 55.6% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-6.33) is lower than that of the sector as a whole (231.08).
P/E vs Market: The company's P/E (-6.33) is lower than that of the market as a whole (141.29).
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.8898) is lower than that of the sector as a whole (3.54).
P/BV vs Market: The company's P/BV (0.8898) is lower than that of the market as a whole (2.85).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (186.81) is higher than that of the sector as a whole (12.89).
P/S vs Market: The company's P/S indicator (186.81) is higher than that of the market as a whole (5.43).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.4358) is lower than that of the sector as a whole (11.15).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.4358) is lower than that of the market as a whole (12.47).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 198.07% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (198.07%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
6.4. ROE
ROE vs Sector: The company's ROE (-100.44%) is lower than that of the sector as a whole (9.99%).
ROE vs Market: The company's ROE (-100.44%) is lower than that of the market as a whole (190.51%).
6.6. ROA
ROA vs Sector: The company's ROA (-93.76%) is lower than that of the sector as a whole (0.4344%).
ROA vs Market: The company's ROA (-93.76%) is lower than that of the market as a whole (173.11%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.35%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '4.26%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
